前白蛋白在急性ST段抬高型心肌梗死中的临床意义
[Abstract]:Acute ST segment elevation myocardial infarction (acute ST-segment elevation myocardial infarction, STEMI) is one of the important diseases that seriously threaten human health. At present, the basic etiology is mainly based on coronary atherosclerosis. Unstable plaque rupture leads to blood, platelet aggregation and secondary thrombosis, and causes coronary artery to cause coronary artery disease. Complete occlusion of the veins causes myocardial ischemia and hypoxia to cause corresponding myocardial damage and irreversible necrosis, which can further trigger the dysfunction of the papillary muscles, acute heart failure, cardiac rupture, embolism, and post infarction syndrome, which seriously affect the treatment strategy of the clinicians and the treatment of the patients and their families. The present study shows that STEMI is urgent. Local and systemic inflammatory responses play an important role in the development and prognosis of the disease. The changes in the level of the variety of serological markers related to local and systemic inflammatory responses, such as C reactive protein (CRP), troponin T (cTnT), brain natriuretic peptide (BNP), and the prognosis of patients with STEMI are being paid more and more attention. Prealbumin (PA) is a homologous four polymer synthesized by the liver. As a fast turnover viscera, PA is considered not only to react to the nitrogen metabolism of the whole body, but also as a better indicator of the nutritional status of the patient, and the serum PA is also a nonspecific defensive protein that can free the subunit of the subunit in the inflammatory response period. The combination of the pathogenic molecules and the toxic metabolites of the body leads to its own consumption and the decrease in serum concentration. In recent years, studies have shown that PA can be used as a predictor of the major adverse events within 1 years after peripheral artery angiography, and the lower level of PA is also associated with the poor prognosis of the heart failure. Some scholars have studied the changes of PA with the severity of coronary artery disease and the short-term prognosis of acute myocardial infarction in patients with Kawasaki disease, coronary heart disease and acute myocardial infarction. It is shown that the index of PA as a response to inflammation and acute stress response is important in assessing the degree of vascular disease, the range of inflammation and the prognosis of the patients in acute myocardial infarction. However, STEMI as a transmural myocardial infarction, compared to stable angina pectoris (stable angina pectoris, SAP), unstable angina pectoris (unstable angina pectoris, UAP), and non ST segment elevation myocardial infarction (non-ST-segment elevation) has different therapeutic options and prognostic outcomes. The relationship between the short-term prognosis of the patients and the PA level is less. Therefore, this study provides a theoretical reference for the clinical drug intervention PA level as a therapeutic target by comparing the relationship between the short-term prognosis and the level of PA in the patients with STEMI. This study adopts a retrospective survey method and continues to be selected from the Department of Cardiology of the first hospital of Zhangjiakou from January 2013 to June 2015, 1 60 STEMI patients, recorded the patient's sex, age, heart rate, systolic blood pressure, past history of hypertension, history of diabetes, smoking history, blood lipid, liver function, heart function and so on. All patients were immediately given elbow vein blood to our hospital for biochemical test. All patients received percutaneous coronary intervention after admission (percut Aneous coronary intervention, PCI), PCI operation was performed by two senior Department of Cardiology interventional physicians in our hospital. The patients were given a load of Aspirin Enteric-coated Tablets 300mg and Clopidogrel Bisulfate Tablets 600mg before operation. The stent implantation standard was the degree of coronary artery stenosis more than 75%, and the number of vascular branches of the three patients was counted. According to STEMI patients, Cardiac events during hospitalization were divided into event group and non event group. 58 cases of event group and 102 cases of non events were treated with SPSS17.0. Independent sample t test was used for the comparison of data groups conforming to normal distribution. The data of 3 or more than 3 groups were analyzed by single factor analysis of variance; non normal distribution data were collected. Using the rank sum test, the count data were compared by the chi square _2 test or the Fisher accurate test; the independent predictors of the cardiovascular events were analyzed by the single variable and multivariable Logistic regression model, and the best threshold for the cardiac events was calculated by the ROC curve of the subjects. All the data tests were both bilateral test, P0.0 5 the difference was statistically significant in 3.STEMI patients with 2 coronary artery stenosis and 1 coronary stenosis, the difference was statistically significant. 2 coronary stenosis patients had lower level of PA than 1 coronary artery stenosis. The.Spearman correlation analysis showed that the level of serum prealbumin and coronary artery were compared with that of coronary artery. The degree of pathological changes was negatively correlated, PA was low in the more severe and acute STEMI patients. Then STEMI patients were divided into event group and non event group. The age of the two groups was compared to the baseline data, and the proportion of the diabetic history was higher than that in the non event group, while the event group was in the male proportion, systolic pressure, prealbumin, left ventricle. The ejection fraction (left ventricular ejection fraction, LVEF) was lower than the non event group. There was no statistical difference between the two groups in heart rate, hypertension history, smoking, left ventricular end diastolic diameter, the ratio of anterior wall myocardial infarction, blood lipid, troponin T and the number of stent placement. It is clear that PA is related to the prognosis of STEMI patients; aspertate amino (aspertate amino). Transferase, AST), the alanine transaminase (ALT) is different. It may be that acute myocardial infarction is the reversible loss of the liver. Subsequently, this study conducted a single factor Logistic analysis of factors that may be associated with the prognosis of the patient. The results showed that sex, age, diabetes history, systolic pressure, LVEF, PA were affected. The factors related to the prognosis of the patients were analyzed. However, multivariate analysis showed that only the history of diabetes, systolic blood pressure, LVEF, and PA were related factors affecting the prognosis of the patients. Then, the results of this study showed that the area under the curve under the curve of PA was 0.709, the difference was statistically significant, and the best threshold was 20.85mg/dl. based on R The threshold values measured by OC were divided into two groups of prealbumin 20.85mg/dl and more than 20.85mg/dl. Compared with group more than 20.85mg/dl, the incidence of ventricular fibrillation, high atrioventricular block, cardiogenic shock, heart failure, heart total adverse events increased in 20.85mg/dl group, while new atrial fibrillation or atrial flutter, postoperative recurrence of heart infarction, and death of two groups were no difference. The results suggest that PA is of great significance for predicting the prognosis of patients with STEMI. The above study suggests that PA may be the same as the traditional predictor as an independent predictor of cardiac events in patients with STEMI during the hospital. Therefore, the routine detection of serum PA in patients with STEMI may be of the possibility of early making and evaluating the prognosis of the patients. Important clinical significance.
【学位授予单位】:河北北方学院
【学位级别】:硕士
【学位授予年份】:2017
【分类号】:R542.22
【参考文献】
相关期刊论文 前10条
1 祖素云;王爽;杨凤兰;陈宝贵;马明哲;;急性心肌梗死患者PCI术后血清前白蛋白的变化及临床意义[J];实用临床医药杂志;2016年07期
2 陈伟伟;高润霖;刘力生;朱曼璐;王文;王拥军;吴兆苏;李惠君;郑哲;蒋立新;胡盛寿;;《中国心血管病报告2014》概要[J];中国循环杂志;2015年07期
3 ;急性ST段抬高型心肌梗死诊断和治疗指南[J];中华心血管病杂志;2015年05期
4 王丹;马增春;李凯;杨长春;;PCI术前高剂量阿托伐他汀钙对STEMI患者血清前白蛋白水平的影响[J];中国药物应用与监测;2015年02期
5 徐升;赵洋;姜艳娜;;左心室容量参数和射血分数检测对预测老年心肌梗死患者预后的价值[J];中国实用医药;2015年04期
6 王丹;李凯;赵海滨;杨长春;;前白蛋白在急性心肌梗死患者中的变化及与预后的关系[J];中华老年心脑血管病杂志;2015年01期
7 金帅;桑真真;贾冬;许云;张鹏思;赵敏;;入院收缩压对急性ST段抬高心肌梗死预后的研究[J];中华急诊医学杂志;2014年08期
8 陈都;包龙;徐峰;陆士奇;;超敏C反应蛋白与前白蛋白比值对心肌梗死并发急性心衰的预测价值[J];中国急救医学;2014年07期
9 王晶;白玉芝;茹静;张琴;汤莉莹;赵霞;;急性冠状动脉综合征患者血清前白蛋白水平变化的临床研究[J];临床荟萃;2007年18期
10 柯元南;陈纪林;;不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J];中华心血管病杂志;2007年04期
,本文编号:2172137
本文链接:https://www.wllwen.com/yixuelunwen/jjyx/2172137.html